Application and development of CRISPR-Cas12a methods for the molecular diagnosis of cancer: A review
- 31 December 2024
- journal article
- review article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1341, 343603
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- The role of sex hormones and receptors in HBV infection and development of HBV‐related HCCJournal of Medical Virology, 2023
- Development of a separation platform comprising magnetic beads combined with the CRISPR/Cas12a system enabling ultrasensitive and rapid detection of miRNA-21Microchimica Acta, 2023
- Validation of novel DNA methylation markers in cervical precancer and cancerInternational Journal of Cancer, 2023
- Light‐Start CRISPR‐Cas12a Reaction with Caged crRNA Enables Rapid and Sensitive Nucleic Acid DetectionAngewandte Chemie International Edition, 2023
- CLIPON: A CRISPR‐Enabled Strategy that Turns Commercial Pregnancy Test Strips into General Point‐of‐Need Test DevicesAngewandte Chemie International Edition, 2022
- CRISPR‐Cas12a System for Biosensing and Gene RegulationChemistry – An Asian Journal, 2021
- CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9Cell Biology and Toxicology, 2019
- The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancerJournal of Cellular Physiology, 2018
- Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editingWIREs RNA, 2018
- MiRNALet‐7a mediates prostate cancer PC‐3 cell invasion, migration by inducing epithelial‐mesenchymal transition through CCR7/MAPK pathwayJournal of Cellular Biochemistry, 2018